The impacts of the COVID-19 pandemic on treatment-resistant schizophrenia patients having followed virtual reality therapy or cognitive behavioural therapy: a content analysis
- PMID: 36102593
- PMCID: PMC9481136
- DOI: 10.1080/07853890.2022.2121852
The impacts of the COVID-19 pandemic on treatment-resistant schizophrenia patients having followed virtual reality therapy or cognitive behavioural therapy: a content analysis
Abstract
Purpose: The COVID-19 pandemic led to exacerbation of mental health symptoms and deterioration in psychological well-being in individuals suffering from schizophrenia. The primary objective of this study is to evaluate the impacts of the COVID-19 pandemic on patients suffering from treatment-resistant schizophrenia (TRS) with auditory verbal hallucinations (AVH) having undergone virtual reality therapy (VRT) or cognitive behavioural therapy (CBT) on their symptomatology. The secondary objective is to identify the differences and similarities in relation to the response to the COVID 19 pandemic between these two groups of patients.
Methods: Qualitative analysis of semi-structured interviews was conducted with 42 patients suffering from TRS who had previously followed VRT or CBT. All interviews were recorded, transcribed, and analysed.
Results: Four themes emerged in this study: Psychotherapeutic Interventions, Impact of COVID-19 and Public health and safety policies, Substance use and Psychiatric follow-up. Participants from both groups reported that their therapy was beneficial in controlling AVH. Patients having followed CBT reported more depressive symptoms whereas patients having followed VRT reported more anxious symptoms.
Conclusions: This study offers a first qualitative insight in patients suffering from TRS and the impacts of COVID-19 on them and opens the door to the protective factors of CBT and VRT for this specific population.
Trial registration: ClinicalTrials.gov NCT03585127.
Keywords: COVID-19; avatar therapy; cognitive behavioural therapy; schizophrenia; virtual reality therapy.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Similar articles
-
Virtual reality therapy for refractory auditory verbal hallucinations in schizophrenia: A pilot clinical trial.Schizophr Res. 2018 Jul;197:176-181. doi: 10.1016/j.schres.2018.02.031. Epub 2018 Feb 24. Schizophr Res. 2018. PMID: 29486956 Clinical Trial.
-
Exploring the Benefits of Virtual Reality-Assisted Therapy Following Cognitive-Behavioral Therapy for Auditory Hallucinations in Patients with Treatment-Resistant Schizophrenia: A Proof of Concept.J Clin Med. 2020 Sep 30;9(10):3169. doi: 10.3390/jcm9103169. J Clin Med. 2020. PMID: 33007909 Free PMC article.
-
Exploring the acceptability, and feasibility of a modified virtual reality-based AVATAR therapy in schizophrenia spectrum disorders: A case series report.Acta Psychol (Amst). 2024 Oct;250:104520. doi: 10.1016/j.actpsy.2024.104520. Epub 2024 Oct 12. Acta Psychol (Amst). 2024. PMID: 39405743
-
Immersive virtual reality in the treatment of auditory hallucinations: A PRISMA scoping review.Psychiatry Res. 2024 Apr;334:115834. doi: 10.1016/j.psychres.2024.115834. Epub 2024 Mar 1. Psychiatry Res. 2024. PMID: 38452499
-
Avatar Therapy for people with schizophrenia or related disorders.Cochrane Database Syst Rev. 2020 May 8;5(5):CD011898. doi: 10.1002/14651858.CD011898.pub2. Cochrane Database Syst Rev. 2020. PMID: 32413166 Free PMC article.
References
-
- Šimunović Filipčić I, Filipčić I.. Schizophrenia and physical comorbidity. Psychiatr Danub. 2018;30(4):152–157. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical